SCHEMBL1695687

SCHEMBL1695687

O=C(O)/C(=C/c1ccc(Cl)cc1)c1ccc(OCc2cn3ccccc3n2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.66
▸ SMN1; SMN2 Q16637 3/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ LMNA P02545 1/20 0.61
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ PDE10A Q9Y233 1/20 0.50
▸ TDP1 Q9NUW8 5/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ TSHR P16473 1/20 0.46
▸ HCRTR1 O43613 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ AKR1C3 P42330 1/20 0.44
▸ AKR1C2 P52895 1/20 0.44
▸ AKR1C1 Q04828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695688 1.00 KDM4E (0.66) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL1695828 0.89 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL1695910 0.89 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL1695814 0.84 KDM4E (0.53) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL4726835 0.82 NPC1 (0.75) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL23488101 0.80 KDM4E (1.00) KDM4ESMN1; SMN2ALDH1A1LMNANPC1
SCHEMBL1695577 0.78 GPBAR1 (0.63) KDM4ESMN1; SMN2ALDH1A1PDE10AMAPT
SCHEMBL7703187 0.78 GPBAR1 (0.63) KDM4ESMN1; SMN2ALDH1A1PDE10AMAPT
SCHEMBL1695576 0.78 GPBAR1 (0.63) KDM4ESMN1; SMN2ALDH1A1PDE10AMAPT
SCHEMBL23488102 0.77 KDM4E (0.80) KDM4ESMN1; SMN2ALDH1A1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
Send feedback